rs34270473
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032861.4(SERAC1):āc.89T>Cā(p.Ile30Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,596,892 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_032861.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERAC1 | NM_032861.4 | c.89T>C | p.Ile30Thr | missense_variant, splice_region_variant | 2/17 | ENST00000647468.2 | NP_116250.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERAC1 | ENST00000647468.2 | c.89T>C | p.Ile30Thr | missense_variant, splice_region_variant | 2/17 | NM_032861.4 | ENSP00000496731.1 |
Frequencies
GnomAD3 genomes AF: 0.00959 AC: 1459AN: 152166Hom.: 26 Cov.: 32
GnomAD3 exomes AF: 0.00245 AC: 616AN: 251006Hom.: 10 AF XY: 0.00173 AC XY: 235AN XY: 135670
GnomAD4 exome AF: 0.000969 AC: 1400AN: 1444608Hom.: 23 Cov.: 28 AF XY: 0.000838 AC XY: 603AN XY: 719758
GnomAD4 genome AF: 0.00963 AC: 1466AN: 152284Hom.: 26 Cov.: 32 AF XY: 0.00926 AC XY: 690AN XY: 74476
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 29, 2016 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 11, 2016 | - - |
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Mar 15, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at